SIPSIP

EN
Banner
ACADEMIC & PATENTS
please select
AMS BioteQ’s Wound Dressing Manufacturing Technology Granted Japanese Invention Patent Approval(圖)
SIPSIP
2026-04-23
AMS BioteQ’s Wound Dressing Manufacturing Technology Granted Japanese Invention Patent Approval
On April 15, 2026, the Company received official notification from the Japan Patent Office (JPO) confirming that its porous artificial dressing manufactured using freeze-drying technology has successfully passed substantive examination and been granted a Japanese invention patent (Application No.: Japanese Patent Application No. 2024-153333).
Dual Certification for SIPSIP Foam Dressings: AMS BioteQ Expands Product Lines to Capture Japan’s Aging Medical Device Market(圖)
SIPSIP
2025-07-30
Dual Certification for SIPSIP Foam Dressings: AMS BioteQ Expands Product Lines to Capture Japan’s Aging Medical Device Market
Dual Certification for SIPSIP Foam Dressings: AMS BioteQ Expands Product Lines to Capture Japan’s Aging Medical Device Market
AMS BioteQ Officially Enters Japan’s Medical Device Market, Obtaining Taiwan’s First Japanese Medical Device Certification(圖)
SIPSIP
2024-07-17
AMS BioteQ Officially Enters Japan’s Medical Device Market, Obtaining Taiwan’s First Japanese Medical Device Certification
AMS BioteQ (Stock Code: 6864) announced on the 11th of this month that its innovative medical care product, SIPSIP Foam, has successfully obtained Class I medical device sales approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA), officially entering the Japanese market.
AMS BioteQ has achieved significant progress in the global wound dressing market by successfully obtaining U.S. FDA approval.(圖)
SIPSIP
2024-01-15
AMS BioteQ has achieved significant progress in the global wound dressing market by successfully obtaining U.S. FDA approval.
AMS BioteQ (TPE: 6864) announced on 11th Dec. last year that its innovative medical care product, "SIPSIPᵀᴹ Foam," the wound dressing made of its patented bioengineering technology ExtrOᵀᴹ, has successfully obtained the registration number issued by the U.S. FDA.
AMS BioteQ Wound Dressing Approved, Expanding into Innovative Medical Care Market(圖)
SIPSIP
2023-12-25
AMS BioteQ Wound Dressing Approved, Expanding into Innovative Medical Care Market
AMS BioteQ (stock code: 6864), a leading biotechnology company, announced on the 21st that its innovative medical care material, "SIPSIP Foam AMS BioteQ Cotton Wound Dressing," has successfully obtained approval from the Taiwan Food and Drug Administration (TFDA), with a medical device approval permit number.